I agree that this site is using cookies. You can find further informations here.
X
Leucht, Katharina
71  results:
Search for persons X
?
1

Reasonability of Frequent Laboratory Analyses during Therap..:

Franke, Klara ; Foller, Susan ; Rosero Moreno, Michele Estephania...
Cancers.  16 (2024)  12 - p. 2287 , 2024
Link: https://doi.org/10.3390/..
 
?
2

A Pooled Analysis of 3 Phase II Trials of Salvage Nivolumab..:

McKay, Rana R ; Leucht, Katharina ; Xie, Wanling...
The Oncologist.  29 (2023)  4 - p. 324-331 , 2023
Link: https://doi.org/10.1093/..
 
?
3

Tailored immunotherapy approach with nivolumab with or with..:

Grimm, Marc-Oliver ; Esteban, Emilio ; Barthélémy, Philippe...
The Lancet Oncology.  24 (2023)  11 - p. 1252-1265 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Management of Immune-Related Adverse Events from Immune-Che..:

Leucht, Katharina ; Ali, Nalyan ; Foller, Susan.
Cancers.  14 (2022)  18 - p. 4369 , 2022
Link: https://doi.org/10.3390/..
 
?
5

Influence of Prostate Artery Embolization on Different Qual..:

Theurich, Anne Tabea ; Leistritz, Lutz ; Leucht, Katharina...
European Urology Focus.  8 (2022)  5 - p. 1323-1330 , 2022
Link: https://doi.org/10.1016/..
 
?
6

iRECIST-based versus non-standardized free text reporting o..:

Schomburg, Laura ; Malouhi, Amer ; Grimm, Marc-Oliver...
Journal of Cancer Research and Clinical Oncology.  148 (2022)  8 - p. 2003-2012 , 2022
Link: https://doi.org/10.1007/..
 
?
7

Therapie des muskelinvasiven und fortgeschrittenen Harnblas..:

Grimm, Marc-Oliver ; Leucht, Katharina ; Leeder, M.
Im Fokus Onkologie.  24 (2021)  S1 - p. 44-53 , 2021
Link: https://doi.org/10.1007/..
 
?
8

Risikostratifizierung und Therapiealgorithmus des metastasi..:

Foller, Susan ; Leucht, Katharina ; Grimm, Marc-Oliver
Der Onkologe.  28 (2021)  2 - p. 167-178 , 2021
Link: https://doi.org/10.1007/..
 
?
9

How to Deal with Renal Cell Carcinoma >7 cm: Radical Surger:

Grimm, Marc-Oliver ; Leucht, Katharina
European Urology Open Science.  33 (2021)  - p. 81-82 , 2021
Link: https://doi.org/10.1016/..
 
?
10

Nebenwirkungen der Immun-Checkpoint-Inhibitor-Therapieurolo..:

Grimm, Marc-Oliver ; Gottschlich, Tobias ; Ali, Nalyan..
Der Urologe.  60 (2021)  6 - p. 803-815 , 2021
Link: https://doi.org/10.1007/..
 
?
11

Erratum zu: Nebenwirkungen der Immun-Checkpoint-Inhibitor-T..:

Grimm, Marc-Oliver ; Gottschlich, Tobias ; Ali, Nalyan..
Der Urologe.  , 2021
Link: https://doi.org/10.1007/..
 
?
12

Re: Avelumab Maintenance Therapy for Advanced or Metastatic..:

Grimm, Marc-Oliver ; Leucht, Katharina
European Urology.  79 (2021)  3 - p. 429-430 , 2021
Link: https://doi.org/10.1016/..
 
?
13

Sequenztherapie des metastasierten Nierenzellkarzinoms:

Foller, Susan ; Leucht, Katharina ; Grimm, Marc-Oliver
best practice onkologie.  16 (2021)  12 - p. 603-611 , 2021
Link: https://doi.org/10.1007/..
 
?
14

Risk Stratification and Treatment Algorithm of Metastatic R..:

Grimm, Marc-Oliver ; Leucht, Katharina ; Foller, Susan
Journal of Clinical Medicine.  10 (2021)  22 - p. 5339 , 2021
Link: https://doi.org/10.3390/..
 
?
15

New First Line Treatment Options of Clear Cell Renal Cell C..:

Grimm, Marc-Oliver ; Leucht, Katharina ; Grünwald, Viktor.
Journal of Clinical Medicine.  9 (2020)  2 - p. 565 , 2020
Link: https://doi.org/10.3390/..
 
1-15